Copyright
©The Author(s) 2021.
World J Gastroenterol. Feb 14, 2021; 27(6): 523-533
Published online Feb 14, 2021. doi: 10.3748/wjg.v27.i6.523
Published online Feb 14, 2021. doi: 10.3748/wjg.v27.i6.523
Figure 1 Comparison of S3 steatosis, F3/4 fibrosis and metabolic syndrome among control (non-diabetic) and study (diabetic) group.
Figure 2 Control and study group patients stratified according to fibrosis stage.
Figure 3 Control and study group patients stratified according to steatosis stage.
Figure 4 Control and study group patients stratified according to number of criteria met for metabolic syndrome.
- Citation: Makker J, Tariq H, Kumar K, Ravi M, Shaikh DH, Leung V, Hayat U, Hassan MT, Patel H, Nayudu S, Chilimuri S. Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study. World J Gastroenterol 2021; 27(6): 523-533
- URL: https://www.wjgnet.com/1007-9327/full/v27/i6/523.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i6.523